Elevance Health (NYSE: ELV) — Company Overview, News & Financial Data
Elevance Health enhances healthcare experiences in the U.S. through personalized health products and community support.
Elevance Health
Elevance Health is an American health company that provides health insurance and health care services across the United States. Operating through its Health Benefits and Carelon business segments, the company offers commercial, Medicare, and Medicaid health plans, alongside specialized services including pharmacy benefit management, behavioral health, complex care coordination, and healthcare analytics. It serves employer groups, government programs, and individual members through licensed Blue Cross and Blue Shield brand affiliates in 14 states and national network partnerships. Headquartered in Indianapolis, Indiana, the company operates an integrated healthcare model combining medical coverage with clinical care solutions.
Snapshot
Operations
Products and/or services of Elevance Health
- Commercial Health Insurance: Individual and group employer health coverage products offered through risk-based and fee-based arrangements, delivering comprehensive medical benefits, network access, and benefit administration across commercial customer segments in licensed territory states.
- Government Healthcare Programs: Medicare Advantage, Medicare Supplement, and Medicaid managed care administration serving senior citizens, disabled individuals, and low-income families through state contracts and federal health insurance programs across multiple jurisdictions.
- Pharmacy Benefit Management: Prescription fulfillment services, home delivery pharmacy solutions, specialty drug management, clinical administration, and rebate management provided for health plan members and corporate healthcare clients across the United States.
- Integrated Care Services: Comprehensive clinical management and care coordination programs focused on complex care, behavioral health, outpatient care management, advanced illness care, and home-based care delivery to optimize patient outcomes.
- Healthcare Technology & Services: Digital health solutions, data analytics, software development, and administrative support infrastructure serving claims processing, clinical workflows, and operational management for healthcare operations and external clients.
- Specialty & Supplemental Benefits: Vision, dental, life, disability, and supplemental health insurance policies provided to individual policyholders and employer groups alongside traditional medical benefit plans to deliver complete population coverage.
Elevance Health executive team
- Gail Koziara BoudreauxPresident, CEO & Director
- Mark Bradley KayeExecutive VP & CFO
- Peter David HaytaianSpecial Advisor
- Charles Morgan Kendrick Jr.EVP and President of Commercial & Specialty Health Benefits
- Felicia Farr NorwoodExecutive VP & Chief Health Benefits Officer
- Scott Wayne AnglinSVP, Treasurer & Chief Investment Officer
- Ronald William PenczekSenior VP, Controller & Chief Accounting Officer
- Nathan Allen RichVice President of Investor Relations
- Erin M. WesslingExecutive VP & Chief Legal Officer
- Julie GoonSenior Vice President of Public Affairs
Latest news about Elevance Health
Elevance Health revenue grows to $50.4 billion in Q3
United StatesHumana jumps 14.4% on Medicare ratings
United StatesHealth insurer stocks decline after 2027 Medicare Advantage plan updates
United StatesElevance Health posts $49.8 billion Q2 revenue
United StatesElevance Health raises 2026 outlook following robust Q1 performance
United StatesElevance Health Executive: Committed to Affordability
Australia
Dividend history
Dividends per share paid by Elevance Health, by financial year.
| Financial year | Interim | Final | Special | Total |
|---|---|---|---|---|
| FY2026(to date) | — | — | — | $6.8800 |
| FY2025 | — | — | — | $6.8400 |
| FY2024 | — | — | — | $6.5200 |
| FY2023 | — | — | — | $5.9200 |
| FY2022 | — | — | — | $5.1200 |
Key financials
Reported results for Elevance Health, in USD.
- Market cap
- 89.7B
- Revenue (TTM)
- 201.8B
- P/E ratio
- 17.6
- EPS (diluted, TTM)
- 23.6
- Dividend yield
- 1.7%
- Profit margin
- 2.5%
| Fiscal year end | Revenue | Operating income | Net income |
|---|---|---|---|
| 199.1B | 8.1B | 5.7B | |
| 176.8B | 8.9B | 6B | |
| 171.3B | 8.7B | 6B | |
| 156.6B | 8.5B | 5.9B |